Tenzing Acquisition in an 8-K filing today said shareholders voted to merge with pharmaceuticals company Reviva. The deal gives the combined company a valuation of $119 million. Read more.
Shareholders Approve Tenzing/Reviva Merger
Related Posts
Advanced Merger Partners Files for $250M IPO
The SPAC's sponsor is an affiliate of investment bank Houlihan Lokey and investment advisory firm Saddle Point.
Maxpro Capital Acquisition Shareholders Approve Apollomics Deal
The SPAC also noted that 10,270,060 shares were redeemed in connection with the vote. That essentially wiped out Maxpro's cash in trust, which originally stood at $105 million. However, last month the SPAC announced PIPE subscriptions totaling $23.65 million -- more than enough to cover the $20 million minimum to close the deal.
Zanite Amends $200M IPO
Zanite Sponsor has committed to purchase $5,500,000 in private placement warrants (or warrants of up to $6,100,000 if the underwriters’ over-allotment option is exercised in full).
Real Estate Behemoth CBRE Group Creates SPAC, Files $400M IPO
CBRE plans to list the SPAC on the NYSE under CBAH.U.